Oncólogos del Occidente S.A.S.

Oncólogos del Occidente S. A. S. , based in Armenia, Colombia, specializes in comprehensive cancer treatment services, offering a range of surgical and medical oncology solutions to enhance patient care and outcomes.

Founded in 1992 in Armenia, Colombia, Oncólogos del Occidente S. A. S. provides specialized cancer treatment services.

The company has engaged in two funding deals, with the most recent occurring on December 9, 2022, when Patria Investments acquired a controlling stake from Victoria Capital Partners. Oncólogos del Occidente S. A. S.

, operating under the brand Zentria, specializes in providing comprehensive cancer treatment services across multiple Colombian cities, including Armenia, Cartago, La Dorada, Manizales, and Pereira. Their core offerings encompass high-complexity surgical procedures, medical oncology consultations, and personalized treatment plans, all supported by a team of specialists trained in oncology sub-specialties. The organization aims to improve patient outcomes and quality of life through innovative cancer therapies, evidenced by over 8,000 surgical interventions. The primary clientele includes cancer patients who require specialized care, as well as healthcare institutions seeking collaborative treatment solutions.

The services are strictly localized to the Colombian healthcare market, addressing the growing need for advanced oncology care in the region. The revenue model for Oncólogos del Occidente S. A. S.

is structured around direct patient transactions for oncology services, including consultations, surgical procedures, and ongoing treatment regimens. Patients, or their insurance providers, typically pay for individual services rendered, which may vary based on the complexity of the procedures and the specific treatment plans developed for each case. Partnerships with local healthcare institutions may also provide a stream of referrals and shared resources, enhancing service delivery. The company’s revenue is bolstered by its reputation for high-quality care, which attracts a steady flow of patients seeking advanced oncology treatments.

Specific pricing plans for their services reflect the intricate nature of cancer care, ensuring that patients receive tailored and comprehensive solutions. Following the acquisition on December 9, 2022, Oncólogos del Occidente S. A. S.

is positioned to maximize its medical treatment capabilities across healthcare facilities. The company plans to develop and launch new oncology treatment products aimed at enhancing patient care. Expansion into additional Colombian cities is also on the agenda, with specific timelines to be determined as part of their growth strategy, supported by the recent investment.